Valeo Financial Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Valeo Financial Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-350	Closed	-$56K	–	951
2021 Q1	$56K	Hold	350	–	–	﹤0.01%	825
2020 Q4	$59K	Hold	350	–	–	﹤0.01%	715
2020 Q3	$55K	Sell	350 -160	-31%	-$26.2K	﹤0.01%	631
2020 Q2	$86K	Buy	+510	New	+$80K	0.01%	550
2019 Q3	–	Sell	-112	Closed	-$16K	–	1594
2019 Q2	$16K	Buy	112 +30	+37%	+$4.14K	﹤0.01%	905
2019 Q1	$12K	Hold	82	–	–	﹤0.01%	920
2018 Q4	$10K	Hold	82	–	–	﹤0.01%	879
2018 Q3	$11K	Hold	82	–	–	﹤0.01%	937
2018 Q2	$12K	Hold	82	–	–	﹤0.01%	899
2018 Q1	$11K	Buy	+82	New	+$11.2K	﹤0.01%	897

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Valeo Financial Advisors's FBT Position: Q2 2021 in Review

Valeo Financial Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2021, closing a stake of 350 shares — an estimated $56K sold.

Valeo Financial Advisors first reported a position in FBT in Q1 2018 and held it in 10 quarters. The position peaked at $86K in Q2 2020. 233 funds tracked by Wall St. Rank hold FBT as of Q2 2021.

Valeo Financial Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2021 after selling out during the quarter.
Valeo Financial Advisors sold 350 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2021, an estimated $56K.
Valeo Financial Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2018 and held it in 10 quarters.
Valeo Financial Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $86K in Q2 2020.
233 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.